Project 1

Title: Title: From precision medicine to drug discovery: Inhibition of Smurf1 activity by a chalcone derivative to promote local bone formation during spinal fusion in distinctive mice subgroup with age-related osteoporosis

Principal Investigator: Dr. Chao Liang 

Funding Body: Natural Science Foundation Council

Project ID: 81700780

Exercise Year: 2018/2020

Approved Project Duration: 36months

Project Fund: RMB 200,000



Project 2

Title: Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma

Principal Investigator: Dr. Fangfei Li

Funding Body: Natural Science Foundation Council

Project ID: 81703049

Exercise Year: 2018/2020

Approved Project Duration: 36 months

Project Fund: RMB 200,000



Project 3

Title: The role of osteoclastic miR-214-3p in subchondral bone remodeling during early osteoarthritis development

Principal Investigator: Dr. Jin Liu

Funding Body: Natural Science Foundation Council

Project ID: 81702189

Exercise Year: 2018/2020

Approved Project Duration: 36 months

Project Fund: RMB 200,000



 

 


版权所有 © 2018 香港浸会大学精准医学与创新药物研究所 - 私隱政策聲明